Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 11/20 | 0.51 |
| ▸ | APP | P05067 | 1/20 | 0.48 |
| ▸ | SELL | P14151 | 3/20 | 0.46 |
| ▸ | SELE | P16581 | 3/20 | 0.46 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
| ▸ | ALPL | P05186 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ALPI | P09923 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALPG | P10696 | 1/20 | 0.43 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | GALK1 | P51570 | 1/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | CASP6 | P55212 | 1/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.43 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19440344 | 1.00 | SELP (0.51) | SELPAPPSELLSELESYNJ2 | |
| SCHEMBL2627817 | 1.00 | SELP (0.51) | SELPAPPSELLSELESYNJ2 | |
| SCHEMBL14401342 | 1.00 | SELP (0.51) | SELPAPPSELLSELESYNJ2 | |
| SCHEMBL2615735 | 1.00 | SELP (0.51) | SELPAPPSELLSELESYNJ2 | |
| SCHEMBL2615729 | 1.00 | SELP (0.51) | SELPAPPSELLSELESYNJ2 | |
| SCHEMBL12738925 | 1.00 | SELP (0.51) | SELPAPPSELLSELESYNJ2 | |
| SCHEMBL2615749 | 1.00 | SELP (0.51) | SELPAPPSELLSELESYNJ2 | |
| SCHEMBL15603823 | 1.00 | SELP (0.51) | SELPAPPSELLSELESYNJ2 | |
| SCHEMBL2615734 | 1.00 | SELP (0.51) | SELPAPPSELLSELESYNJ2 | |
| SCHEMBL31533677 | 1.00 | SELP (0.51) | SELPAPPSELLSELESYNJ2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025026555-A1 | ALDOXIMES AS NO DONORS, AND THEIR USES AS PLANT ARCHITECTURE MODIFIERS AND IN THERAPY | Universidad Pública de Navarra (ES) | 2025-02-06 | — | — | WO | disclosed |
| US-20250020371-A1 | METHODS, COMPOSITIONS AND SYSTEMS FOR SOLID-STATE BAROCALORIC APPLICATIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2025-01-16 | — | — | US | disclosed |
| US-20240230171-A1 | METHODS, COMPOSITIONS AND SYSTEMS FOR SOLID-STATE BAROCALORIC APPLICATIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2024-07-11 | — | — | US | disclosed |
| EP-4320205-A1 | METHODS, COMPOSITIONS AND SYSTEMS FOR SOLID-STATE BAROCALORIC APPLICATIONS | President and Fellows of Harvard College (US) | 2024-02-14 | — | — | EP | disclosed |
| WO-2022216969-A1 | METHODS, COMPOSITIONS AND SYSTEMS FOR SOLID-STATE BAROCALORIC APPLICATIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-10-13 | — | — | WO | disclosed |
| US-9586985-B2 | Organic compounds as proantigens for natural killer T cells | VICTORIA LINK LIMITED (NZ) | 2017-03-07 | — | — | US | disclosed |
| US-20150191503-A1 | ORGANIC COMPOUNDS | VICTORIA LINK LIMITED (NZ) | 2015-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240230171-A1 | METHODS, COMPOSITIONS AND SYSTEMS FOR SOLID-STATE BAROCALORIC APPLICATIONS | GCN1, CA3, SCO2 | SELP 3729/4885APP 4620/4885SELL 3561/4885 |
| US-20150191503-A1 | ORGANIC COMPOUNDS | SGMS1, UGCG, SGMS2 | SELP 488/4885APP 484/4885SELL 1188/4885 |
| US-20250020371-A1 | METHODS, COMPOSITIONS AND SYSTEMS FOR SOLID-STATE BAROCALORIC APPLICATIONS | GCN1, CA3, SCO2 | SELP 3729/4885APP 4620/4885SELL 3561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.